aica ribonucleotide and Heart Diseases

aica ribonucleotide has been researched along with Heart Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Timm, KN; Tyler, DJ	1
Cao, Y; Gu, C; Han, Y; Sun, G; Wang, Y; Wang, Z; Xu, M; Yin, Q; Zhu, H	1

Reviews

1 review(s) available for aica ribonucleotide and Heart Diseases

Article	Year
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity. Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:2 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Caloric Restriction; Cardiotoxicity; Doxorubicin; Enzyme Activation; Enzyme Activators; Exercise; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondria, Heart; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Thiazolidinediones	2020

Article

Year

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.

Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:2

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Caloric Restriction; Cardiotoxicity; Doxorubicin; Enzyme Activation; Enzyme Activators; Exercise; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondria, Heart; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Thiazolidinediones

2020

Other Studies

1 other study(ies) available for aica ribonucleotide and Heart Diseases

Article	Year
Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder. Cardiovascular therapeutics, 2018, Volume: 36, Issue:6 Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Cardiopulmonary Bypass; Creatine Kinase, MB Form; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Glucose Metabolism Disorders; Glucose Transporter Type 4; GTPase-Activating Proteins; Heart Diseases; Male; Myocardium; Phosphorylation; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Troponin I	2018

Article

Year

Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder.

Cardiovascular therapeutics, 2018, Volume: 36, Issue:6

Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Cardiopulmonary Bypass; Creatine Kinase, MB Form; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Glucose Metabolism Disorders; Glucose Transporter Type 4; GTPase-Activating Proteins; Heart Diseases; Male; Myocardium; Phosphorylation; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Troponin I

2018